BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8837236)

  • 1. Comparison of chemotaxis and superoxide generation of indium-111-oxine- and technetium-99m-HMPAO-labelled granulocytes.
    Stoeckli TC; Zimmerli W; Maecke HR; Fridrich R
    Scand J Clin Lab Invest; 1996 Jul; 56(4):305-9. PubMed ID: 8837236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparison of equine granulocytes labeled with 99mTc-hexamethylpropyleneamine oxime or 111In-oxine.
    Daniel GB; Tucker RL; Buckman T; Daniel SL
    Am J Vet Res; 1992 Jun; 53(6):871-6. PubMed ID: 1626776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results.
    Becker W; Schomann E; Fischbach W; Börner W; Gruner KR
    Nucl Med Commun; 1988 Jun; 9(6):435-47. PubMed ID: 3137513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic of Tc-99m-anti-NCA-95-Moab in vitro labelled granulocytes in comparison to in-vivo Moab-labelled and In-111-oxine-labelled granulocytes.
    Becker W; Marienhagen J; Ordnung D; Wolf F
    Prog Clin Biol Res; 1990; 355():151-8. PubMed ID: 2126372
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease.
    Allan RA; Sladen GE; Bassingham S; Lazarus C; Clarke SE; Fogelman I
    Eur J Nucl Med; 1993 Mar; 20(3):195-200. PubMed ID: 8462606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content.
    Blocklet D; Toungouz M; Kiss R; Lambermont M; Velu T; Duriau D; Goldman M; Goldman S
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):440-7. PubMed ID: 12722741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three different methods for radiolabelling human activated T lymphocytes.
    Botti C; Negri DR; Seregni E; Ramakrishna V; Arienti F; Maffioli L; Lombardo C; Bogni A; Pascali C; Crippa F; Massaron S; Remonti F; Nerini-Molteni S; Canevari S; Bombardieri E
    Eur J Nucl Med; 1997 May; 24(5):497-504. PubMed ID: 9142729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional upregulation of granulocytes labeled with technetium-99m-HMPAO and indium-111-oxinate.
    Bertrand-Caix J; Freyburger G; Bordenave L; Labrouche S; Bareille R; Baquey C; Ducassou D; Lefebvre F
    J Nucl Med; 1996 May; 37(5):863-8. PubMed ID: 8965165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of inflammatory bowel disease (IBD) and scintigraphic assessment of resected colon: comparison of 111 In-oxine and 99mTC HMPAO leucocyte labelling.
    Moisan A; Lecloirec J; Bretagne JF; Loreal O; Raoul JL; Herry JY
    Prog Clin Biol Res; 1990; 355():159-64. PubMed ID: 2126373
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of white cell scintigraphy using indium-111 and technetium-99m labelled leucocytes.
    Boyd SJ; Nour R; Quinn RJ; McKay E; Butler SP
    Eur J Nucl Med; 1993 Mar; 20(3):201-6. PubMed ID: 8462607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.
    Peters AM; Roddie ME; Danpure HJ; Osman S; Zacharopoulos GP; George P; Stuttle AW; Lavender JP
    Nucl Med Commun; 1988 Jun; 9(6):449-63. PubMed ID: 3412733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m and indium-111 double labelling of granulocytes for kinetic and clinical studies.
    Aktolun C; Ussov WY; Arka A; Glass D; Gunasekera RD; Peters AM
    Eur J Nucl Med; 1995 Apr; 22(4):330-4. PubMed ID: 7607263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucocyte radiolabelling techniques: practical aspects.
    Frier M
    Scand J Gastroenterol Suppl; 1994; 203():32-5. PubMed ID: 7973446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labeled granulocyte scanning for the diagnosis of infected necrosis in acute pancreatitis: what kind of labeling should be used?
    Heresbach D; Devillers A; Rabot A; Moisan A; Malledant Y; Bourguet P; Bretagne JF; Gosselin M
    Pancreas; 1996 May; 12(4):381-7. PubMed ID: 8740406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods.
    Mansfield JC; Giaffer MH; Tindale WB; Holdsworth CD
    Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of technetium-99m-HM-PAO leukocytes with indium-111-oxine leukocytes for localizing intraabdominal sepsis.
    Mountford PJ; Kettle AG; O'Doherty MJ; Coakley AJ
    J Nucl Med; 1990 Mar; 31(3):311-5. PubMed ID: 2106576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment.
    Becker W; Bair J; Behr T; Repp R; Streckenbach H; Beck H; Gramatzki M; Winship MJ; Goldenberg DM; Wolf F
    J Nucl Med; 1994 Sep; 35(9):1436-43. PubMed ID: 8071688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labelling of leucocytes with technetium-99m exametazime causes in vitro upregulation of granulocyte CD11b without correlation to tissue uptake in vivo.
    Almer S; Ljunghusen O; Lundahl J
    Eur J Nucl Med; 1996 Jun; 23(6):669-74. PubMed ID: 8662101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytes labelled with 99mTc-HMPAO in vitro studies and preliminary clinical experience.
    Hardeman MR
    Prog Clin Biol Res; 1990; 355():49-54. PubMed ID: 2149183
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphological and functional status of leukocytes labelled with 99m technetium HMPAO.
    De Labriolle-Vaylet C; Linhart NC; Petiet A; Bok B
    Prog Clin Biol Res; 1990; 355():119-29. PubMed ID: 2177895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.